Primary Health Properties (LON: PHP) is the topic of conversation when Hardman & Co Analyst Mike Foster joins DirectorsTalk. Mike explains who PHP are, what they do, dividends from multiple
Filta Group (LON:FLTA) provides cleaning services to commercial kitchens in North America, the UK and, more recently, mainland Europe. The company reported a strong set of figures for FY18, in
ValiRx Plc (LON:VAL) is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment of cancer. The company has two leading assets: VAL201 (Phase I/II) – a peptide
Tissue Regenix (LON:TRX) has a broad portfolio of regenerative medicine products for the biosurgery, orthopaedics, dental and cardiac markets. It has two proprietary decellularisation technology platforms for the repair of
Over the last few weeks, most of the multi-national pharmaceutical companies have reported results for 2018, which has given us the opportunity to update our industry statistics and drug database.
Y2K is a numeronym and was the common abbreviation for the year 2000 software problem; and, for the benefit of millennial readers, the abbreviation combines the letter ‘Y’ for year
Genedrive plc (LON:GDR) is a commercial-stage company focused on point-of-care (PoC) molecular diagnostics. Its Genedrive® molecular diagnostic platform is at the forefront of this technology, offering a rapid, low-cost, simple-to-use
Hardman & Co Analyst Mark Thomas joins DirectorsTalk to discuss Volta Finance (LON: VTAS). Mark provides us with some background on the company, details around the managers March presentation and explains how covenant
Artificial Solutions (ASAI.SE) is a vendor of highly advanced artificial intelligence (AI)-based conversational solutions. Its Teneo technology platform is used by major global enterprises to automate their interactions with their own
Although the focus of Hardman & Co is predominantly on companies in the small- to mid-sized market capitalisation range, when writing research reports, it is important to position them relative
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
